Hydromorphone

ATC CodeN02AA03
CAS number466-99-9
PUB number5284570
Drugbank IDDB00327
Empirical formulaC17H19NO3
Molar mass (g·mol−1)285,34
Physical statesolid
Melting point (°C)266–267
PKS value8,2

Basics

Hydromorphone, also known as dihydromorphinone, is an opioid used to treat moderate to severe pain. Typically, long-term use is recommended only for pain due to cancer. It can be taken by mouth or by injection into a vein, muscle, or under the skin. The effect generally starts within half an hour and lasts up to five hours.

Pharmacology

Pharmacodynamics

Hydromorphone is a semisynthetic μ-opioid agonist. As a hydrogenated ketone of morphine, it shares pharmacological properties typical of opioid analgesics. Hydromorphone and related opioids exert their main effects in the central nervous system and gastrointestinal tract. Binding to μ-opioid receptors in the brain results in hydromorphone's potent analgesic effects.

Pharmacokinetics

Chemical modification of the morphine molecule to hydromorphone results in higher lipid solubility and easier crossing of the blood-brain barrier. This allows the drug to reach the receptors in the brain more quickly, resulting in a faster onset of action. The potency of hydromorphone is approximately 5 times that of morphine.

The typical half-life of intravenous hydromorphone is 2.3 hours. Maximum plasma levels usually occur between 30 and 60 minutes after oral administration. The onset of action of intravenous hydromorphone is less than 5 minutes and within 30 minutes of oral administration (immediate release).

Toxicity

Side effects

Common side effects are dizziness, drowsiness, nausea, itching, and constipation. Severe side effects may include low blood pressure, seizures, respiratory depression, and serotonin syndrome. Rapidly lowering the dose can lead to opioid withdrawal. In general, use during pregnancy or lactation is not recommended.

As with all opioids, there is a risk of abuse and dependence.

Toxicological Data

LD50 (mouse, i.v.): 104 mg-kg-1

Sources

  • Drugbank
  • PubChem
  • Aktories, Förstermann, Hofmann, Starke: Allgemeine und spezielle Pharmakologie und Toxikologie, Elsvier, 2017
Markus Falkenstätter, BSc

Markus Falkenstätter, BSc

Mag. pharm. Stefanie Lehenauer

Mag. pharm. Stefanie Lehenauer



Logo

Your personal medication assistant

Drugs

Browse our extensive database of medications from A-Z, including effects, side effects, and dosage.

Substances

All active ingredients with their effects, applications, and side effects, as well as the medications they are contained in.

Diseases

Symptoms, causes, and treatments for common diseases and injuries.

Social media

The presented content does not replace the original package insert of the medication, especially regarding the dosage and effects of individual products. We cannot assume liability for the accuracy of the data, as the data has been partially converted automatically. Always consult a doctor for diagnoses and other health-related questions.

© medikamio